Insider · CIK 0001171118
C Ronald Blankenship
Files at REG (REGENCY CENTERS CORP), CVEO (Civeo Corp). First filing -, latest -.
In brief
C Ronald Blankenship files SEC Form 4 as director at REG (REGENCY CENTERS CORP), and also at CVEO (Civeo Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; C Ronald Blankenship has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +167 | - | - | 114,923 | Aug 7, 2026 |
| May 27, 2026 | CVEO Civeo Corp | AGrant or award Common Shares | +3,624 | $0.00 | $0 | 54,446 | May 27, 2026 |
| May 11, 2026 | REG REGENCY CENTERS CORP | MOption exercise Common Stock | +1,875 | - | - | 114,679 | May 12, 2026 |
| May 11, 2026 | REG REGENCY CENTERS CORP | MOption exercise Common Stock | +77 | - | - | 114,756 | May 12, 2026 |
| May 11, 2026 | REG REGENCY CENTERS CORP | MOption exercise Restricted Stockderivative | -1,875 | $0.00 | $0 | 0 | May 12, 2026 |
| May 11, 2026 | REG REGENCY CENTERS CORP | MOption exercise Dividend Equivalent Rightsderivative | -77 | $0.00 | $0 | 0 | May 12, 2026 |
| May 6, 2026 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +453 | - | - | 112,804 | May 8, 2026 |
| Feb 4, 2026 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +481 | - | - | 112,351 | Feb 5, 2026 |
| Nov 6, 2025 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +473 | - | - | 111,870 | Nov 7, 2025 |
| Aug 8, 2025 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +479 | - | - | 111,397 | Aug 8, 2025 |
| May 14, 2025 | CVEO Civeo Corp | AGrant or award Common Shares | +6,021 | $0.00 | $0 | 50,822 | May 15, 2025 |
| May 12, 2025 | REG REGENCY CENTERS CORP | AGrant or award Restricted Stock Grantderivative | +1,875 | $0.00 | $0 | 1,875 | May 14, 2025 |
| May 5, 2025 | REG REGENCY CENTERS CORP | MOption exercise Common Stock | +2,284 | - | - | 110,346 | May 7, 2025 |
| May 5, 2025 | REG REGENCY CENTERS CORP | MOption exercise Common Stock | +91 | - | - | 110,437 | May 7, 2025 |
| May 5, 2025 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +481 | - | - | 110,918 | May 7, 2025 |
| May 5, 2025 | REG REGENCY CENTERS CORP | MOption exercise Restricted Stockderivative | -2,284 | $0.00 | $0 | 91 | May 7, 2025 |
| May 5, 2025 | REG REGENCY CENTERS CORP | MOption exercise Dividend Equivalent Rightsderivative | -91 | $0.00 | $0 | 0 | May 7, 2025 |
| Feb 10, 2025 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +478 | - | - | 108,541 | Feb 12, 2025 |
| Nov 12, 2024 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +506 | - | - | 108,063 | Nov 13, 2024 |
| Nov 1, 2023 | REG REGENCY CENTERS CORP | AGrant or award Common Stock | +554 | - | - | 94,208 | Nov 3, 2023 |
Questions about C Ronald Blankenship
Answered from the filings on this page, as of the latest one.
Is C Ronald Blankenship buying or selling?
C Ronald Blankenship has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did C Ronald Blankenship's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and C Ronald Blankenship has 0.
Where does C Ronald Blankenship file Form 4?
C Ronald Blankenship has filed Form 4 at REG (REGENCY CENTERS CORP); CVEO (Civeo Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.